BioNTech SE

BioNTech Insider Buying Spurs Confidence: CFO & Execs Buy €89.38‑Priced Options

BioNTech insider buying signals executive confidence in mRNA and oncology growth—understanding the regulatory context, market fundamentals and strategic implications.

BioNTech SE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/05/2026, 22:28

6 minutes to read

BioNTech Insider Sale: Poetting’s 50,000 Shares Won’t Sink Momentum – What Investors Need to Know

BioNTech insider sale by COO Sierk Poetting: 50,000 shares sold amid rising shares, strong oncology pipeline and resilient liquidity – not a bearish signal.

BioNTech SE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

23/04/2026, 22:18

3 minutes to read